| III-39 Sarah Lobet Influence of body composition on the pharmacokinetics of monoclonal antibodies : example of cetuximab and bevacizumab Thursday 10:15-11:45 |
| III-39 Sarah Lobet Influence of body composition on the pharmacokinetics of monoclonal antibodies : example of cetuximab and bevacizumab Thursday 10:15-11:45 |